ReproCELL Inc. (4978) Financial Statements

0 Followers

ReproCELL Inc. Financial Overview

ReproCELL Inc.'s market cap is currently ¥16.07B. The company's EPS TTM is ¥; its P/E ratio is -28.17; ReproCELL Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	¥ 2.23B	¥ 2.98B	¥ 2.43B	¥ 2.95B	¥ 2.23B
Gross Profit	¥ 1.01B	¥ 1.63B	¥ 1.10B	¥ 1.13B	¥ 785.42M
Operating Income	¥ -860.06M	¥ -130.41M	¥ -409.29M	¥ -356.22M	¥ -647.13M
EBITDA	¥ -785.10M	¥ -79.70M	¥ -372.18M	¥ -307.23M	¥ -587.37M
Net Income	¥ -591.69M	¥ 103.25M	¥ -31.41M	¥ -305.31M	¥ -575.10M
Balance Sheet
Cash & Short-Term Investments	¥ 6.51B	¥ 3.94B	¥ 6.57B	¥ 6.38B	¥ 4.64B
Total Assets	¥ 9.65B	¥ 9.67B	¥ 9.05B	¥ 8.36B	¥ 8.10B
Total Debt	¥ 0.00	¥ 0.00	¥ 0.00	¥ 0.00	¥ 80.00M
Net Debt	¥ -2.60B	¥ -2.82B	¥ -2.94B	¥ -1.91B	¥ -2.56B
Total Liabilities	¥ 805.59M	¥ 685.81M	¥ 741.03M	¥ 780.63M	¥ 844.53M
Stockholders' Equity	¥ 8.85B	¥ 8.98B	¥ 8.31B	¥ 7.58B	¥ 7.25B
Cash Flow
Free Cash Flow	¥ -481.75M	¥ -80.40M	¥ -182.89M	¥ -290.92M	¥ -289.65M
Operating Cash Flow	¥ -383.53M	¥ 6.29M	¥ -11.45M	¥ -140.53M	¥ -246.24M
Investing Cash Flow	¥ 57.94M	¥ -796.00M	¥ 404.42M	¥ -1.09B	¥ -2.14B
Financing Cash Flow	¥ 0.00	¥ 680.11M	¥ 544.05M	¥ 482.87M	¥ 2.38B

Currency in JPY

ReproCELL Inc. Earnings and Revenue History

Income Statement >

ReproCELL Inc. Debt to Assets

Balance Sheet >

ReproCELL Inc. Cash Flow

Cash Flow >

ReproCELL Inc. Forecast EPS vs Actual EPS

Earnings >